Head-to-head · WeighScore
Liberty vs PauseRX
By GLP-1 ScorecardUpdated
Score comparison
PauseRX has the higher recorded score — 68.5/100 to 61/100.
PauseRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PauseRX advertises no membership fee and separate starting prices for its compounded programs. Check the supply, next charge and order cutoff for your plan.
Before you choose
Liberty does not publish a semaglutide price, so its Liberty review sets out what it does disclose, while the PauseRX review explains the conditions attached to PauseRX's figure. The semaglutide cost page compares published rates across the field. Ask Liberty for a written total before treating either one as the cheaper choice.
If neither one fits, Liberty vs Synergy Rx and Medi-Weightloss vs PauseRX compare each of them with another graded program, and the list of alternatives to Liberty ranks the programs closest to Liberty on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Lttl review covers one graded close to these two, at 63.5/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Liberty | PauseRX |
|---|---|---|
| WeighScore | 61/100 | 68.5/100 |
| Grade | C | C |
| Site position | #331 | #162 |
| Semaglutide | Conflicting price displays | Compounded GLP-1 from $199; confirm selected supply and charge |
| Tirzepatide | Conflicting price displays | Compounded GLP-1/GIP from $249; confirm selected supply and charge |
| Coverage | Coverage not published | Confirm availability for the selected product and state |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Not confirmed | Yes |
Strengths
- Shows one- and three-month choices for both advertised compounds.
- Publishes separate subscription and medication refund terms.
What to consider
- The selector and product copy disagree on monthly prices.
- The subscription cutoff depends on the scheduled shipment.
Strengths
- Publishes starting prices for its two compounded programs
- Lists brand-name options separately
- Publishes a prescription final-sale policy
What to consider
- Starting prices do not establish the full debit or refill charge
- The returns policy makes charged orders final after carrier handoff
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.